Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Evaluation of the antipruritic effect of Elidel (pimecrolimus) in non-atopic pruritic disease
2005-005638-10Phase 2Completed
- Sponsor
- Universität Münster
- Start
- Sep 2006
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of pimecrolimus in prurigo nodularis (PN) (2 arms), sponsored by Universität Münster. Primary endpoint: Total symptom score of prurigo nodularis lesions. Started Sep 2006; status: completed.
02
Drugs
pimecrolimus
03
Conditions
prurigo nodularis (PN)
Beyond the preview
Go deeper on 2005-005638-10.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-005638-10.